<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05052918</url>
  </required_header>
  <id_info>
    <org_study_id>EXERCISECIMT</org_study_id>
    <nct_id>NCT05052918</nct_id>
  </id_info>
  <brief_title>The Effect of Exercise and Metformin on Carotid Intima-media Thickness in Patients With Prediabetes</brief_title>
  <official_title>The Effect of Exercise and Metformin on Carotid Intima-media Thickness in Patients With Prediabetes</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate whether there is a change in carotid intima media&#xD;
      thickness with the application of guide-based exercise programs in individuals with&#xD;
      prediabetes, and to evaluate whether there is a difference between the group in which&#xD;
      exercise programs were applied and those who received only lifestyle change and metformin.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The researchers think that the application of guide-based exercise programs in prediabetes&#xD;
      patients will decrease the carotid intima-media thickness.The aim of this study is to&#xD;
      evaluate whether there is a change in carotid intima media thickness with the application of&#xD;
      guide-based exercise programs in individuals with prediabetes, and to evaluate whether there&#xD;
      is a difference between the group in which exercise programs were applied and those who&#xD;
      received only lifestyle change and metformin.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">September 8, 2021</start_date>
  <completion_date type="Anticipated">March 15, 2022</completion_date>
  <primary_completion_date type="Anticipated">March 15, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Carotid ultrasound</measure>
    <time_frame>12 weeks</time_frame>
    <description>milimeter size of carotid intima media thickness</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Pre Diabetes</condition>
  <condition>Exercise</condition>
  <condition>Metformin</condition>
  <condition>Atherosclerosis</condition>
  <arm_group>
    <arm_group_label>Exercise</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients with prediabetes undergoing a 12-week exercise program&#xD;
(1 hour of moderate-intensity aerobic exercise 3 days a week for 12 weeks)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients with prediabetes with no intervention</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Metformin</arm_group_label>
    <arm_group_type>No Intervention</arm_group_type>
    <description>Patients with prediabetes using metformin</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Exercise</intervention_name>
    <description>1 hour of moderate-intensity aerobic exercise 3 days a week for 12 weeks</description>
    <arm_group_label>Exercise</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Leading a sedentary life&#xD;
&#xD;
          -  Those who have sufficient motivation to participate in the exercise program (will be&#xD;
             evaluated by a one-on-one interview by the researchers)&#xD;
&#xD;
          -  Have the same weight for 6 months before participating in the study (±2.5 kg)&#xD;
&#xD;
          -  Those diagnosed with prediabetes by oral glucose tolerance test and/or HbA1c&#xD;
             measurement&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Serious medical condition (for example, advanced malignancy or major neurological,&#xD;
             psychiatric or endocrine disease, respiratory failure, etc.) that would prevent the&#xD;
             person from participating in exercise training.&#xD;
&#xD;
          -  Having cardiovascular disease&#xD;
&#xD;
          -  Being diabetic&#xD;
&#xD;
          -  Using metformin before participating in the study&#xD;
&#xD;
          -  Receiving hormone replacement therapy&#xD;
&#xD;
          -  Life expectancy less than 1 year&#xD;
&#xD;
          -  HIV positivity&#xD;
&#xD;
          -  Substance use&#xD;
&#xD;
          -  Functional dependency&#xD;
&#xD;
          -  Cognitive weakness&#xD;
&#xD;
          -  Those who have other diseases that will affect the results of the study (respiratory&#xD;
             diseases, muscle diseases, etc.)&#xD;
&#xD;
          -  Those who use drugs or supplements that will affect the results of the study&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Elif Yıldırım Ayaz, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Sultan Abdülhamid Han Training and Research Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Elif Yıldırım Ayaz, M.D.</last_name>
    <phone>+905325148300</phone>
    <email>drelifyildirim@hotmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Emine Şeyma Denli Yalvaç, M.D.</last_name>
    <phone>+905057311317</phone>
    <email>seymadenli@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Sultan Abdülhamid Han Training and Research Hospital</name>
      <address>
        <city>Üsküdar</city>
        <state>İstanbul</state>
        <zip>34668</zip>
        <country>Turkey</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Elif Yıldırım Ayaz, M.D.</last_name>
      <phone>+905325148300</phone>
      <email>drelifyildirim@hotmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Emine Şeyma Denli Yalvaç, M.D.</last_name>
      <phone>+905057311317</phone>
      <email>seymadenli@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>September 2021</verification_date>
  <study_first_submitted>September 7, 2021</study_first_submitted>
  <study_first_submitted_qc>September 12, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">September 22, 2021</study_first_posted>
  <last_update_submitted>September 12, 2021</last_update_submitted>
  <last_update_submitted_qc>September 12, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">September 22, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Prediabetes</keyword>
  <keyword>exercise</keyword>
  <keyword>metformin</keyword>
  <keyword>atherosclerosis</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Atherosclerosis</mesh_term>
    <mesh_term>Prediabetic State</mesh_term>
    <mesh_term>Glucose Intolerance</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

